Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Marker Therapeutics
MRKR
$18.8M
| $99K | ﹤0.01% |
31,950
+12,600
| +65% | +$21.9K |
|
|
AIOS
3477
AIOS Tech
AIOS
$38.4M
| $99K | ﹤0.01% |
1,338
-273
| -17% | -$24.7K |
|
|
RTB
3478
RTB Digital
RTB
$214M
| $99K | ﹤0.01% |
377
+93
| +33% | +$20.3K |
|
|
YQ
3479
17 Education & Technology Group
YQ
$17M
| $99K | ﹤0.01% |
21,411
-1,613
| -7% | -$8.97K |
|
|
ONCT
3480
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $99K | ﹤0.01% |
14,350
+1,595
| +13% | +$10.5K |
|
3481
Lulu's Fashion Lounge
LVLU
$46.6M
| $98K | ﹤0.01% |
2,573
-567
| -18% | -$20.7K |
|
3482
SOPHiA GENETICS
SOPH
$476M
| $97K | ﹤0.01% |
21,600
-2,500
| -10% | -$11.3K |
|
|
CAMP
3483
DELISTED
CalAmp Corp.
CAMP
| $97K | ﹤0.01% |
3,961
+678
| +21% | +$32.9K |
|
|
VRPX
3484
DELISTED
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
| $97K | ﹤0.01% |
357
-24
| -6% | -$4.97K |
|
3485
Eton Pharmaceutcials
ETON
$1.27B
| $96K | ﹤0.01% |
27,600
+14,200
| +106% | +$52.2K |
|
3486
Imunon
IMNN
$6.68M
| $95K | ﹤0.01% |
5,674
+950
| +20% | +$15.7K |
|
3487
QuickLogic
QUIK
$232M
| $95K | ﹤0.01% |
+10,300
| New | +$65.4K |
|
|
ACER
3488
DELISTED
Acer Therapeutics Inc
ACER
| $95K | ﹤0.01% |
102,552
-9,248
| -8% | -$8.2K |
|
3489
Aveanna Healthcare
AVAH
$2.04B
| $94K | ﹤0.01% |
55,400
+4,500
| +9% | +$5.64K |
|
3490
Regis Corp
RGS
$68.4M
| $94K | ﹤0.01% |
4,251
-14,814
| -78% | -$319K |
|
3491
Team
TISI
$79.5M
| $94K | ﹤0.01% |
11,369
-900
| -7% | -$5.21K |
|
|
BVC
3492
BitVentures Limited Ordinary Shares
BVC
$1.88B
| $94K | ﹤0.01% |
13,600
| – | – |
|
|
ENG
3493
DELISTED
ENGlobal Corp
ENG
| $94K | ﹤0.01% |
31,013
-337
| -1% | -$1.1K |
|
|
SALM
3494
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
| $93K | ﹤0.01% |
97,200
+2,700
| +3% | +$2.68K |
|
3495
AYTU BioPharma
AYTU
$23.9M
| $92K | ﹤0.01% |
57,323
+7,700
| +16% | +$15.1K |
|
|
IMA
3496
ImageneBio Inc
IMA
$63M
| $92K | ﹤0.01% |
+1,175
| New | +$84.3K |
|
|
AGPU
3497
Axe Compute Inc
AGPU
$95.4M
| $92K | ﹤0.01% |
1,258
+570
| +83% | +$34.6K |
|
|
SYBX
3498
DELISTED
Synlogic
SYBX
| $92K | ﹤0.01% |
14,287
+8,160
| +133% | +$68.2K |
|
|
QXO
3499
QXO Inc
QXO
$13.8B
| $91K | ﹤0.01% |
3,388
-787
| -19% | -$19.9K |
|
|
OMIC
3500
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $91K | ﹤0.01% |
3,657
+2,907
| +388% | +$85.2K |
|
Similar funds
Renaissance Technologies's Q2 2023 Portfolio in Review
As of Q2 2023, Renaissance Technologies held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Berkshire Hathaway Class A worth $316M.
- Renaissance Technologies's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Renaissance Technologies added most to Apple in Q2 2023, an estimated $856M increase.
- Renaissance Technologies's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Renaissance Technologies fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Renaissance Technologies's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Renaissance Technologies opened 542 new positions and closed 599 in Q2 2023.
- Renaissance Technologies's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.